You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cisplatin-intolerant

Showing 1 - 25 of 3,023
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Cervical Carcinoma Trial (CECIL Patient Decision Aid)

Not yet recruiting
  • Locally Advanced Cervical Carcinoma
  • CECIL Patient Decision Aid
  • (no location specified)
Jan 17, 2023

Bladder Cancer Trial (Disitamab Vedotin for Injection,Penpulimab Injection)

Not yet recruiting
  • Bladder Cancer
  • Disitamab Vedotin for Injection,Penpulimab Injection
  • (no location specified)
Aug 2, 2022

Non Small Cell Lung Cancer Trial in Guangzhou (SI-B001, AP or TP, Docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center (SYSUCC)
Mar 14, 2022

HNSCC Trial in Chengdu (Nituozumab)

Recruiting
  • HNSCC
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital and Research Institute
Apr 16, 2023

Neoadjuvant Immunotherapy Trial in Tianjin (tislelizumab+disitamab-vedotin)

Recruiting
  • Neoadjuvant Immunotherapy
  • Tianjin, China
    The Second Hospital of Tianjin Medical University
Apr 20, 2023

Esophageal Squamous Cell Carcinoma Trial in China (Anlotinib Hydrochloride, Paclitaxel, cisplatin)

Active, not recruiting
  • Esophageal Squamous Cell Carcinoma
  • Anlotinib Hydrochloride, Paclitaxel, cisplatin
  • Anyang, Henan, China
  • +5 more
Aug 23, 2021

Advanced NSCLC Trial in Jilin (pemetrexed, Cetuximab, cis-platinum)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Jilin, Changchun, China
    Jilin Province Cancer Hospital
Aug 15, 2022

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Small-cell Lung Cancer Trial in Shanghai (TQB2450)

Recruiting
  • Small-cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jan 25, 2021

Hypercholesterolemia Trial in Japan (K-877 0.2 mg/day (once daily), K-877 0.4 mg/day (once daily), Placebo (once daily))

Recruiting
  • Hypercholesterolemia
  • K-877 0.2 mg/day (once daily)
  • +2 more
  • Aichi, Japan
  • +14 more
Jun 20, 2023

Small-cell Lung Cancer Trial (BGB-A317 Plus Chemotherapy (Cisplatin and Etoposide))

Not yet recruiting
  • Small-cell Lung Cancer
  • BGB-A317 Plus Chemotherapy (Cisplatin and Etoposide)
  • (no location specified)
Jan 25, 2021

Heart Failure Trial (Finerenone, Placebo)

Not yet recruiting
  • Heart Failure
  • (no location specified)
Sep 11, 2023

Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 24, 2023

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

Recruiting
  • Neoadjuvent
  • +3 more
  • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
  • Xi'an, Shaanxi, China
  • +2 more
Aug 17, 2023

Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 12, 2023

Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

Recruiting
  • Healthy (For Part A)
  • Chronic Myeloid Leukemia (for Part B and C)
  • Vodobatinib (K0706) capsules
  • Downey, California
  • +69 more
Dec 7, 2022

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

Not yet recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • ZG006
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 6, 2023

Advanced Solid Tumor Trial in Beijing (SY-3505)

Recruiting
  • Advanced Solid Tumor
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 15, 2023

Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)

Recruiting
  • Ototoxicity, Drug-Induced
  • Sodium Thiosulfate
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 6, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Solid Tumor, Breast Cancer, Pancreatic Cancer Trial in United States (SON-DP)

Recruiting
  • Solid Tumor
  • +4 more
  • Gilbert, Arizona
  • +4 more
Aug 4, 2023

Non-small-cell Lung Carcinoma Trial in Beijing (SY-3505)

Recruiting
  • Non-small-cell Lung Carcinoma
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 11, 2023

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Worldwide (M7824)

Completed
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Scottsdale, Arizona
  • +32 more
Oct 21, 2022

Drug Toxicity Trial in Rawalpindi (N-Acetylcysteine, Chemotherapy)

Active, not recruiting
  • Drug Toxicity
  • Rawalpindi, Punjab, Pakistan
    Medical Oncology department, Fauji Foundation Hospital
Aug 25, 2023